French Biotech Stock News

Voltalia (ENXTPA:VLTSA) is back in focus after its subsidiary Renvolt signed a turnkey EPC contract for ESB’s 124.2 megawatt Wexford Hub solar project in Ireland, expanding an already active partnership. See our latest analysis for Voltalia. Despite the new EPC win in Ireland and recent updates on its share capital and upcoming full year results, Voltalia’s €7.04 share price sits on a year to date share price return of 13.78% decline and a five year total shareholder return of 67.54% decline,...

January traffic update and why it matters for Aeroports de Paris stock Aeroports de Paris (ENXTPA:ADP) reported January 2026 group traffic of 29,503,007 passengers, a 5.0% year on year increase. This is putting fresh attention on how this operational momentum lines up with the current share price. See our latest analysis for Aeroports de Paris. The January traffic news comes at a time when Aeroports de Paris’ share price has picked up, with a 12.44% one-month share price return and 9.93%...

Vicat (ENXTPA:VCT) has laid out its latest scorecard with FY 2025 first half revenue of €1.9b and basic EPS of €2.28, set against trailing twelve month revenue of €3.9b and EPS of €6.17 that frame the current run rate. Over recent periods the group has seen revenue move between €1.9b and €2.0b per half year while basic EPS has ranged from €2.28 to €3.83. This gives investors a clear view of how earnings track against a broadly stable top line as net profit margins edge slightly higher year on...

Sartorius Stedim Biotech (ENXTPA:DIM) has put fresh numbers on the table for FY 2025, with fourth quarter revenue of €772.2 million and basic EPS of €0.49, alongside trailing twelve month EPS of €2.73 and total revenue of €2.97 billion setting the backdrop for the year. The company has seen quarterly revenue move from €655.4 million in Q3 2024 to €772.2 million in Q4 2025, while basic EPS has shifted from €0.26 to €0.49 over the same span. This gives investors a clear view of how top line and...

In early February 2026, Vinci SA reported past full-year 2025 results showing revenue of €75.37 billion and net income of €4.90 billion, alongside higher earnings per share. The Board also proposed lifting the 2025 dividend to €5.00 per share and issued guidance for further revenue and net income growth in 2026, underlining strong cash generation despite higher French taxes. Next, we will assess how Vinci’s record free cash flow and increased 2025 dividend proposal influence its existing...

Earnings strength and a new flagship lease reshape the picture Gecina (ENXTPA:GFC) has just paired a fresh set of full year 2025 results with a firm 9 year lease agreement for its Signature office project in central Paris, giving investors new information on both earnings and portfolio visibility. See our latest analysis for Gecina. The latest 1 day share price return of 1.06% to €75.95 comes after a firm 9 year lease signing and strong 2025 earnings. However, the 1 year total shareholder...

If you are wondering whether TotalEnergies shares still offer value at around €64.16, it helps to step back and look at what the current price might already be pricing in. The stock has recently shown strong momentum, with returns of 2.4% over 7 days, 13.0% over 30 days, 14.4% year to date, 15.8% over 1 year and 131.1% over 5 years. Recent news coverage around TotalEnergies has focused on its positioning in the global energy sector and ongoing portfolio adjustments. This helps frame how...

Earnings pressure and a higher dividend proposal draw attention to TF1 TF1 (ENXTPA:TFI) has come into focus after reporting full year 2025 results showing lower sales and net income, while at the same time proposing a higher €0.63 per share dividend for shareholder approval. See our latest analysis for TF1. The earnings miss and higher dividend proposal appear to have weighed on sentiment, with a 1 day share price return showing a 5.67% decline and a 7 day share price return showing a 15.06%...

LVMH Moët Hennessy - Louis Vuitton Société Européenne (ENXTPA:MC) has reshuffled its senior leadership, with Véronique Courtois and Antoine Arnault joining the group executive committee, a move that could influence how investors think about long term governance. See our latest analysis for LVMH Moët Hennessy - Louis Vuitton Société Européenne. These leadership changes come after a period where momentum has softened, with a 30 day share price return showing a 14.92% decline and a year to date...

BNP Paribas (ENXTPA:BNP) has been active on several fronts recently, with new moves in private debt, Japanese logistics real estate, battery energy storage, and SME financing, giving investors fresh information to assess the stock. See our latest analysis for BNP Paribas. At a share price of €90.84, BNP Paribas has a 90 day share price return of 36.21% and a 1 year total shareholder return of 43.17%. This suggests momentum has picked up recently after a softer 7 day share price move, as...

Hermès International Société en commandite par actions ( EPA:RMS ) came out with its full-year results last week, and...

Crédit Agricole (ENXTPA:ACA) has drawn fresh attention after releasing its fourth quarter and full year 2025 results, along with a proposed 2025 dividend of €1.13 per share, with payment scheduled for 28 May 2026. See our latest analysis for Crédit Agricole. At a share price of €18.03, Crédit Agricole has a 90 day share price return of 13.51%, while its 1 year total shareholder return of 25.56% and 5 year total shareholder return of 131.50% point to momentum that has been building over...

Rémy Cointreau (ENXTPA:RCO) is in focus after Rémy Martin introduced two V.S.O.P This Is My City limited edition bottles for Miami and Los Angeles, paired with $20,000 microgrants and mentorship for local creatives. See our latest analysis for Rémy Cointreau. These city focused releases arrive as the share price has gained momentum in the short term, with a 1 month share price return of 11.20% and a year to date share price return of 24.68%. However, the 1 year total shareholder return of a...

Capgemini (ENXTPA:CAP) has drawn fresh attention after reporting 2025 earnings, issuing 2026 revenue guidance of around 6.5% to 8.5% growth at constant exchange rates, and outlining a recommended €3.40 per share dividend. See our latest analysis for Capgemini. The earnings release, 2026 guidance and new cloud and AI partnerships with Microsoft, AWS and Google Cloud come as momentum in the shares has weakened, with a 30 day share price return of 28.18% and a 1 year total shareholder return of...

Rexel (ENXTPA:RXL) has given investors a packed update that combines full-year 2025 earnings, fresh 2026 sales guidance, a maintained cash dividend proposal and confirmation of completed share buybacks. See our latest analysis for Rexel. The latest update appears to have kept interest in Rexel alive, with the share price at €36.6 and a 30-day share price return of 6.33% and a 90-day share price return of 19.69%, alongside a 1-year total shareholder return of 44.40%. Taken together, these...

Eiffage (ENXTPA:FGR) is in focus after its Spanish subsidiary, Eiffage Energia Sistemas, secured more than €80 million in contracts to build onshore wind farm infrastructure for Capital Energy in Castile and Leon. See our latest analysis for Eiffage. Eiffage’s latest contracts in Spain land at a time when momentum in the shares has been strong, with a 30 day share price return of 15.87% and a 1 year total shareholder return of 58.67%, which points to growing optimism about the company’s...

Publicis Groupe (ENXTPA:PUB) has launched a share buyback program of up to €175 million, starting 13 February 2026. The program is intended to cover existing employee share-based incentives without issuing new shares. See our latest analysis for Publicis Groupe. Despite the buyback announcement and recent initiatives such as the proposed 2025 cash dividend of €3.75 per share and the launch of the Influential Sports unit, Publicis Groupe’s 30 day share price return of 15.69% and year to date...

What the latest trading statement tells you about Neurones Neurones (ENXTPA:NRO) just reported unaudited 2025 figures, with revenue of €857.2 million for the year and €225 million in Q4, and a higher operating margin in the second half. See our latest analysis for Neurones. Despite the stronger 2025 trading statement, the recent performance has been weak, with a 30 day share price return showing a 13.7% decline and a 1 year total shareholder return indicating a 22.5% loss, which suggests...

Assystem (EPA:ASY) has had a rough week with its share price down 8.5%. But if you pay close attention, you might find...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

The board of Signaux Girod S.A. ( EPA:ALGIR ) has announced that it will pay a dividend on the 9th of April, with...

Why Sartorius Stedim Biotech is Back on Investors’ Radar Sartorius Stedim Biotech (ENXTPA:DIM) recently issued 2026 sales growth guidance of around 5% to 9%, providing a fresh data point that gives investors a clearer anchor for expectations after a difficult few years. See our latest analysis for Sartorius Stedim Biotech. The 4.01% 1 day share price return to €174.95 came after the 2026 sales growth guidance and followed a 17.98% 30 day share price decline. The 5 year total shareholder...

In the past week, Renault attracted attention ahead of its 18 February 2026 earnings report, as investors focused on potential margin recovery in its electric vehicle and financing businesses. This renewed interest highlights how quickly sentiment can shift when a company’s profitability in newer segments, such as EVs and financial services, appears poised for change. We’ll now examine how this optimism around electric vehicle margin recovery could influence Renault’s broader investment...

If you are wondering whether Compagnie de Saint-Gobain shares offer solid value at around €90.86, the key is to look past the headline price and focus on how the market is actually pricing the business. The stock has returned 2.9% over the past week and 8.2% over the past month, while the 1 year return sits at a 3.9% decline and the 3 year and 5 year returns are 81.5% and 141.0% respectively. This gives a mixed picture for anyone trying to judge risk and reward. Recent news coverage around...